Cardiol Therapeutics (CRDL) Inventory Average (2021 - 2022)
Cardiol Therapeutics (CRDL) posted Inventory Average of $262948.8 for Q3 2022, down 1.44% on a QoQ basis from $266802.0 in Q2 2022, and down 3.54% year-over-year from $272586.2 in Q3 2021.
Cardiol Therapeutics (CRDL) Inventory Average (2021 - 2022) Analysis & Trends
Cardiol Therapeutics' Inventory Average history runs 2 years deep, the most recent figure standing at $262948.8 for Q3 2022.
- Quarterly Inventory Average fell 3.54% year-over-year to $262948.8 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $262948.8 (down 3.54% YoY) and the FY2021 annual result came in at $141980.2, changed N/A from the prior year.
- Inventory Average was $262948.8 for Q3 2022 at Cardiol Therapeutics, down from $266802.0 in the prior quarter.
- Across five years, Inventory Average topped out at $272586.2 in Q3 2021 and bottomed at $262948.8 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 262,948.78 |
| Jun 30, 2022 | 266,801.95 |
| Mar 31, 2022 | 268,326.91 |
| Dec 31, 2021 | 269,163.33 |
| Sep 30, 2021 | 272,586.23 |